In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Agilent Technologies (NYSE:A) in relation to its major competitors in the Life Sciences Tools & Services industry. Through a detailed examination of key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and illuminate company's performance in the industry.
Agilent Technologies Background
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
---|---|---|---|---|---|---|---|
Agilent Technologies Inc | 34.82 | 6.89 | 6.38 | 5.78% | $0.49 | $0.91 | -5.58% |
Thermo Fisher Scientific Inc | 37.12 | 4.68 | 5.19 | 3.54% | $2.97 | $4.39 | -4.93% |
Danaher Corp | 43.86 | 3.43 | 7.71 | 2.04% | $1.03 | $1.62 | -23.95% |
IQVIA Holdings Inc | 34.14 | 7.41 | 3.09 | 7.87% | $0.87 | $1.39 | 3.45% |
West Pharmaceutical Services Inc | 49.29 | 9.87 | 9.91 | 4.77% | $0.21 | $0.28 | 3.29% |
Waters Corp | 31.62 | 17.64 | 6.87 | 21.03% | $0.32 | $0.5 | -4.55% |
Avantor Inc | 53.28 | 3.23 | 2.44 | 1.9% | $0.29 | $0.57 | -4.02% |
Charles River Laboratories International Inc | 28.81 | 3.79 | 3.31 | 5.42% | $0.32 | $0.36 | -7.85% |
Bruker Corp | 32.09 | 9.30 | 4.62 | 15.89% | $0.28 | $0.43 | 20.62% |
Revvity Inc | 71.53 | 1.62 | 4.67 | 1.01% | $0.16 | $0.38 | -6.11% |
Medpace Holdings Inc | 45.30 | 22.14 | 6.79 | 15.2% | $0.1 | $0.14 | 26.47% |
Bio-Techne Corp | 49.80 | 5.54 | 9.76 | 1.39% | $0.07 | $0.18 | 0.37% |
Repligen Corp | 249.84 | 5.23 | 16.32 | -1.29% | $0.01 | $0.07 | -16.61% |
Stevanato Group SPA | 52.60 | 6.78 | 7.06 | 4.06% | $0.08 | $0.1 | 9.77% |
Sotera Health Co | 65.28 | 7.49 | 3.17 | 9.44% | $0.15 | $0.18 | 23.31% |
Average | 60.33 | 7.72 | 6.49 | 6.59% | $0.49 | $0.76 | 1.38% |